DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVAX (Q2019359): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Changed an Item: Label in wikidata changed) |
||
| label / en | label / en | ||
DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVAX | |||
Revision as of 10:03, 17 March 2020
Project in Italy financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVAX |
Project in Italy financed by DG Regio |
Statements
565,360.84 Euro
0 references
761,887.32 Euro
0 references
74.20530899503616 percent
0 references
1 November 2016
0 references
31 December 2018
0 references
GENOMIX4LIFE SRL
0 references
Q277381 (Deleted Item)
0 references
40°44'48.98"N, 14°46'11.96"E
0 references
BIOTECNOLOGIE (Italian)
0 references
Identifiers
B18I17000200008
0 references